Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Somero Enterprises Inc. (DI) (SOM) by Steve Moore in ShareProphets
- Avoid Intercede Group (IGP) by Steve Moore in ShareProphets
- Overweight Unite Group (UTG) by JP Morgan
- Buy European Green Transition (EGT) by Tom Winnifrith in ShareProphets
- Buy European Green Transition (EGT) by Steve Moore in ShareProphets
- Buy Spectra Systems Corporation (SPSY) by Hot Stock Rockets in ShareProphets
- Hold Robert Walters (RWA) by Deutsche Bank
- Buy Bodycote (BOY) by Jefferies
- Hold Bytes Technology Group (BYIT) by Jefferies
- Buy AstraZeneca (AZN) by Jefferies
- Buy AO World (AO.) by Jefferies
- Hold Unite Group (UTG) by Jefferies
- Buy Convatec Group (CTEC) by Jefferies
- Buy Wise Class A (WISE) by Jefferies
- Hold Whitbread (WTB) by Deutsche Bank
- Avoid Celebrus Technologies (CLBS) by Steve Moore in ShareProphets
- Neutral Tate & Lyle (TATE) by UBS
- Buy Wise Class A (WISE) by UBS
- Buy BAE Systems (BA.) by UBS
- Buy Rolls-Royce Holdings (RR.) by UBS
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,264 open tips for AstraZeneca (AZN)
| Latest Bid : 15,266.00p | Latest Ask : 15,270.00p |
| High Today : 15,450.00p | Low Today : 15,235.69p |
| This Years High : 15,450.00p | This Years Low : 10,008.00p |
| Volume : 720,765 | MKT Cap : £236065M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Jefferies | Premium Only | 2026-04-10 12:01:00 10/04/2026 | -1.13% |
| Buy | Citi | Premium Only | 2026-04-10 07:42:00 10/04/2026 | -0.12% |
| Add | Simon Watkins | Premium Only | 2026-04-08 07:00:00 08/04/2026 | -0.68% |
| Buy | Jefferies | Premium Only | 2026-03-06 04:48:00 06/03/2026 | 2.16% |
| Buy | UBS | Premium Only | 2026-02-26 05:52:00 26/02/2026 | 0.57% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 15,266.00p | Latest Ask : 15,270.00p |
| High Today : 15,450.00p | Low Today : 15,235.69p |
| This Years High : 15,450.00p | This Years Low : 10,008.00p |
| Volume : 720,765 | MKT Cap : £236065M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Jefferies | Premium Only | 2026-04-10 12:01:00 10/04/2026 | -1.13% |
| Buy | Citi | Premium Only | 2026-04-10 07:42:00 10/04/2026 | -0.12% |
| Add | Simon Watkins | Premium Only | 2026-04-08 07:00:00 08/04/2026 | -0.68% |
| Buy | Jefferies | Premium Only | 2026-03-06 04:48:00 06/03/2026 | 2.16% |
| Buy | UBS | Premium Only | 2026-02-26 05:52:00 26/02/2026 | 0.57% |